New Drug Applications Archive

New Drug Applications: January 2004

January 1	Aventis Submits New Drug Application to FDA for Asthma Drug Alvesco (ciclesonide)
January 14	Andrx Receives FDA Approvable Letter for its Valproate NDA
January 15	New Drug Application Submitted for Once-Daily Allegra-D (fexofenadine HCl 180 mg/pseudoephedrine HCl 240 mg) Formulation Using aaiPharma's Development Expertise
January 21	Micrologix Meets with FDA on MBI-226
January 22	Vicuron Pharmaceuticals Announces 90-Day Extension of FDA Review of Anidulafungin New Drug Application
January 28	SuperGen completes submission of New Drug Application (NDA) for Orathecin as an oral treatment for pancreatic cancer
January 28	Alcon Files NDA for Combination Drug to Treat Glaucoma; Releases Preliminary Clinical Data at Major Ophthalmology Meeting
January 28	Pfizer Submits Supplemental New Drug Application Requesting Changes in Geodon Product Label
January 30	Inspire Pharmaceuticals Announces Outcome of Meeting with the FDA on Diquafosol

2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec


Or browse a complete list of drug names A B C D E F G H I J K L M N O P Q R S T U V W X Y Z	Advanced Search